Home/Filings/4/A/0001445815-25-000007
4/A//SEC Filing

PLATT DAVID 4/A

Accession 0001445815-25-000007

CIK 0001445815other

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 3:54 PM ET

Size

7.0 KB

Accession

0001445815-25-000007

Insider Transaction Report

Form 4/AAmended
Period: 2024-10-24
PLATT DAVID
DirectorCEO10% Owner
Transactions
  • Other

    preferred

    2024-10-24$0.55/sh+11,433,448$6,231,22920,038,903 total
  • Other

    preferred

    2024-10-24$0.28/sh14,085,410$4,014,3420 total(indirect: through NDPD Pharma)
Footnotes (3)
  • [F1]The shares were returned to treasury and cancelled
  • [F2]The total holdings of BIXT by NDPA Pharma, an affiliate whose beneficial ownership includes David Platt, Ola Soderquist and Mike Sheikh were consolidated under indirect ownership in David Platt's filing
  • [F3]The shares were issued as payment for the sale of NDPD to Bioxytran

Issuer

BIOXYTRAN, INC

CIK 0001445815

Entity typeother

Related Parties

1
  • filerCIK 0001166440

Filing Metadata

Form type
4/A
Filed
Nov 17, 7:00 PM ET
Accepted
Nov 18, 3:54 PM ET
Size
7.0 KB